Theodore E. Hebert

Array ( [id] => 10735932 [patent_doc_number] => 20160082082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'USE OF THERAPEUTIC PEPTIDES FOR THE TREATMENT AND PREVENTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/849402 [patent_app_country] => US [patent_app_date] => 2015-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8539 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996262 [patent_doc_number] => 20160193208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alpha' [patent_app_type] => utility [patent_app_number] => 14/847545 [patent_app_country] => US [patent_app_date] => 2015-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14847545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11850307 [patent_doc_number] => 20170224799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'IDENTIFICATION OF IMMUNOLOGICALLY PROTECTIVE NEO-EPITOPES FOR THE TREATMENT OF CANCERS' [patent_app_type] => utility [patent_app_number] => 15/501919 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18119 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769062 [patent_doc_number] => 20160115217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'COMPOSITIONS OF HUMANIZED NOTCH FUSION PROTEINS AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/844642 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 143 [patent_figures_cnt] => 143 [patent_no_of_words] => 43554 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11276096 [patent_doc_number] => 09492566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Antibody-drug conjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/844772 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 48 [patent_no_of_words] => 42197 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13648331 [patent_doc_number] => 09850472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => P97-antibody conjugates and methods of use [patent_app_type] => utility [patent_app_number] => 14/837662 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 52 [patent_no_of_words] => 30684 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11350240 [patent_doc_number] => 20160368980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'INHIBITION OF GRANULOCYTE COLONY STIMULATING FACTOR IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/832031 [patent_app_country] => US [patent_app_date] => 2015-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14997 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15306511 [patent_doc_number] => 10517937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Immunotherapy for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/503916 [patent_app_country] => US [patent_app_date] => 2015-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 12229 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14485161 [patent_doc_number] => 10329347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL [patent_app_type] => utility [patent_app_number] => 14/827337 [patent_app_country] => US [patent_app_date] => 2015-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 35 [patent_no_of_words] => 19582 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17133726 [patent_doc_number] => 11135262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Methods of treating cervical cancer [patent_app_type] => utility [patent_app_number] => 15/503997 [patent_app_country] => US [patent_app_date] => 2015-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 70 [patent_no_of_words] => 61279 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10676645 [patent_doc_number] => 20160022790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'VACCINE FOR THE PREVENTION OF BREAST CANCER RECURRENCE' [patent_app_type] => utility [patent_app_number] => 14/813927 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13291 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15130085 [patent_doc_number] => 10478479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Method for preparing dendritic cell, dendritic cell prepared thereby, and use thereof [patent_app_type] => utility [patent_app_number] => 15/327933 [patent_app_country] => US [patent_app_date] => 2015-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 8967 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10990376 [patent_doc_number] => 20160187320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'ASSAY FOR SCREENING COMPOUNDS THAT SELECTIVELY DECREASE THE NUMBER OF CANCER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/808514 [patent_app_country] => US [patent_app_date] => 2015-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 26064 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14808514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11728083 [patent_doc_number] => 20170189526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'Suppression of Myeloid Derived Suppressor Cells and Immune Checkpoint Blockade' [patent_app_type] => utility [patent_app_number] => 15/326186 [patent_app_country] => US [patent_app_date] => 2015-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11069 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11742919 [patent_doc_number] => 20170196990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT' [patent_app_type] => utility [patent_app_number] => 15/324517 [patent_app_country] => US [patent_app_date] => 2015-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19357 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17235554 [patent_doc_number] => 11179417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Method for obtaining globally activated monocytes [patent_app_type] => utility [patent_app_number] => 15/323219 [patent_app_country] => US [patent_app_date] => 2015-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 31 [patent_no_of_words] => 28225 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11766972 [patent_doc_number] => 09375489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Antibody-SN-38 immunoconjugates with a CL2A linker' [patent_app_type] => utility [patent_app_number] => 14/789375 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 62229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489832 [patent_doc_number] => 20150374853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'BRAIN TUMOR TARGETING PEPTIDES AND METHODS' [patent_app_type] => utility [patent_app_number] => 14/789549 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15050 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11668523 [patent_doc_number] => 20170157243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'MANF as a Regulator of Immune System Function' [patent_app_type] => utility [patent_app_number] => 15/321708 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23791 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10669682 [patent_doc_number] => 20160015827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'ANTI-FOLATE RECEPTOR ALPHA (FRA) ANTIBODY-DRUG CONJUGATES AND METHODS OF USING THEREOF' [patent_app_type] => utility [patent_app_number] => 14/745336 [patent_app_country] => US [patent_app_date] => 2015-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39215 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745336 [rel_patent_id] =>[rel_patent_doc_number] =>)